课题基金 / 基金详情

18F-NaF PET-CT Imaging and Blood Biomarker Analysis as Tools to Predict Patients at Risk of Developing Severe Aortic Valve Calcification

18F-NaF PET-CT Imaging and Blood Biomarker Analysis as Tools to Predict Patients at Risk of Developing Severe Aortic Valve Calcification
18F-NaF PET-CT 成像和血液生物标志物分析作为预测患者发生严重主动脉瓣钙化风险的工具
批准号：
441253
负责人：
Gharibeh Lara
金额：
$6.56万
依托单位：
University of Ottawa Heart Institute
依托单位国家：
加拿大
项目类别：
Fellowship Programs
财政年份：
2020
资助国家：
加拿大
项目状态：
已结题
起止时间：
2020-12-01 至 2022-12-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=441253&lang=en
关键词：
Aortic Sclerosis Aortic Stenosis Aortic Valve Calcification Aortic Valve Degeneration Biomarker Analysis Sodium Fluoride Pet-Ct Imaging

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Calcific aortic valve degeneration (CAVD) is the most common heart valve disease worldwide and is increasing exponentially in our aging population. Over time and with aging, the normal aortic valve undergoes structural changes leading to its thickening wh
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金